PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.

Quarter-by-quarter ownership
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2023$185,000
+3.4%
310,124
-0.3%
0.00%0.0%
Q2 2023$179,000
+35.6%
311,124
+66.1%
0.00%0.0%
Q1 2023$132,000
-68.8%
187,2640.0%0.00%
-50.0%
Q4 2022$423,000
+193.8%
187,264
+315.1%
0.00%
+100.0%
Q3 2022$144,000
-15.8%
45,1140.0%0.00%0.0%
Q2 2022$171,000
-66.0%
45,114
-51.7%
0.00%
-50.0%
Q1 2022$503,000
-61.4%
93,359
-3.2%
0.00%
-50.0%
Q4 2021$1,303,000
-26.8%
96,481
-2.6%
0.00%
-33.3%
Q3 2021$1,779,000
+2.4%
99,064
-2.2%
0.01%0.0%
Q2 2021$1,738,000
-5.6%
101,293
+10.1%
0.01%
-14.3%
Q1 2021$1,841,000
+24.2%
92,027
+5.6%
0.01%0.0%
Q4 2020$1,482,000
+27.4%
87,179
+24.3%
0.01%
+16.7%
Q3 2020$1,163,000
-25.1%
70,130
+4.7%
0.01%
-33.3%
Q2 2020$1,552,000
+31.6%
66,999
+1.4%
0.01%
+12.5%
Q1 2020$1,179,000
-4.4%
66,075
+15.6%
0.01%
+33.3%
Q4 2019$1,233,000
+16.2%
57,137
-1.9%
0.01%0.0%
Q3 2019$1,061,000
-48.7%
58,263
+0.1%
0.01%
-45.5%
Q2 2019$2,070,000
+6.0%
58,177
+0.2%
0.01%
+10.0%
Q1 2019$1,952,000
+2.4%
58,087
+0.2%
0.01%
-9.1%
Q4 2018$1,906,000
-51.0%
57,973
-9.1%
0.01%
-42.1%
Q3 2018$3,886,000
+24.2%
63,743
-0.5%
0.02%
+18.8%
Q2 2018$3,130,00064,0940.02%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders